109 related articles for article (PubMed ID: 36738855)
21. DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer.
Drouillard A; Puleo F; Bachet JB; Ouazzani S; Calomme A; Demetter P; Verset G; Van Laethem JL; Maréchal R
Br J Cancer; 2016 Nov; 115(10):1245-1252. PubMed ID: 27755532
[TBL] [Abstract][Full Text] [Related]
22. Expression Patterns and Prognostic Value of DNA Damage Repair Proteins in Resected Pancreatic Neuroendocrine Neoplasms.
Hua J; Shi S; Xu J; Wei M; Zhang Y; Liu J; Zhang B; Yu X
Ann Surg; 2022 Feb; 275(2):e443-e452. PubMed ID: 32209898
[TBL] [Abstract][Full Text] [Related]
23. Ribonucleotide reductase M2 does not predict survival in patients with resectable pancreatic adenocarcinoma.
Xie H; Lin J; Thomas DG; Jiang W; Liu X
Int J Clin Exp Pathol; 2012; 5(4):347-55. PubMed ID: 22670179
[TBL] [Abstract][Full Text] [Related]
24. Prognostic effects of abnormal DNA damage response protein expression in breast cancer.
Suh KJ; Ryu HS; Lee KH; Kim H; Min A; Kim TY; Yang Y; Lee HB; Moon HG; Han SW; Oh DY; Han W; Park IA; Noh DY; Im SA
Breast Cancer Res Treat; 2019 May; 175(1):117-127. PubMed ID: 30671767
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Factors of Adjuvant Taxane, Cisplatin, and 5-Fluorouracil Chemotherapy for Patients With Penile Squamous Cell Carcinoma After Regional Lymphadenectomy.
Necchi A; Lo Vullo S; Nicolai N; Raggi D; Giannatempo P; Colecchia M; Catanzaro M; Torelli T; Piva L; Biasoni D; Stagni S; Mariani L; Salvioni R
Clin Genitourin Cancer; 2016 Dec; 14(6):518-523. PubMed ID: 27050716
[TBL] [Abstract][Full Text] [Related]
26. S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma.
Bachet JB; Maréchal R; Demetter P; Bonnetain F; Cros J; Svrcek M; Bardier-Dupas A; Hammel P; Sauvanet A; Louvet C; Paye F; Vaillant JC; André T; Closset J; Salmon I; Emile JF; Van Laethem JL
Eur J Cancer; 2013 Aug; 49(12):2643-53. PubMed ID: 23726265
[TBL] [Abstract][Full Text] [Related]
27. Correlation between BRCA1 expression and clinicopathological factors including brain metastases in patients with non-small-cell lung cancer.
Gachechiladze M; Uberall I; Kolek V; Klein J; Krejci V; Stastna J; Radova L; Fridman E; Skarda J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Sep; 157(3):227-32. PubMed ID: 23128816
[TBL] [Abstract][Full Text] [Related]
28. Prognostic roles of human equilibrative transporter 1 (hENT-1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancer.
Kim R; Tan A; Lai KK; Jiang J; Wang Y; Rybicki LA; Liu X
Cancer; 2011 Jul; 117(14):3126-34. PubMed ID: 21264835
[TBL] [Abstract][Full Text] [Related]
29. Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma.
Maréchal R; Mackey JR; Lai R; Demetter P; Peeters M; Polus M; Cass CE; Salmon I; Devière J; Van Laethem JL
Cancer; 2010 Nov; 116(22):5200-6. PubMed ID: 20669326
[TBL] [Abstract][Full Text] [Related]
30. The prognostic effect of single and multiple cancer-related somatic mutations in resected non-small-cell lung cancer.
Jao K; Tomasini P; Kamel-Reid S; Korpanty GJ; Mascaux C; Sakashita S; Labbé C; Leighl NB; Liu G; Feld R; Bradbury PA; Hwang DM; Pintilie M; Tsao MS; Shepherd FA
Lung Cancer; 2018 Sep; 123():22-29. PubMed ID: 30089591
[TBL] [Abstract][Full Text] [Related]
31. Association of Germline Variants in Human DNA Damage Repair Genes and Response to Adjuvant Chemotherapy in Resected Pancreatic Ductal Adenocarcinoma.
Hu H; Zhu Y; Pu N; Burkhart RA; Burns W; Laheru D; Zheng L; He J; Goggins MG; Yu J
J Am Coll Surg; 2020 Nov; 231(5):527-535.e14. PubMed ID: 32659497
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the Prognostic Value of Two Common Variants of BRCA1 and BRCA2 Genes in Ovarian Cancer Patients Treated with Cisplatin and Paclitaxel: A Gynecologic Oncology Group Study.
Tian CQ; Darcy KM; Krivak TC; Deloia JA; Armstrong D; Davis W; Zhao H; Moysich K; Ambrosone CB
Front Oncol; 2013; 3():206. PubMed ID: 23964347
[TBL] [Abstract][Full Text] [Related]
33. Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer.
Chen D; Chen H; Chi L; Fu M; Wang G; Wu Z; Xu S; Sun C; Xu X; Lin L; Cheng J; Jiang W; Dong X; Lu J; Zheng J; Chen G; Li G; Zhuo S; Yan J
JAMA Netw Open; 2021 Nov; 4(11):e2136388. PubMed ID: 34846524
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic cancer screening in high-risk individuals with germline genetic mutations.
DaVee T; Coronel E; Papafragkakis C; Thaiudom S; Lanke G; Chakinala RC; Nogueras González GM; Bhutani MS; Ross WA; Weston BR; Lee JH
Gastrointest Endosc; 2018 Jun; 87(6):1443-1450. PubMed ID: 29309780
[TBL] [Abstract][Full Text] [Related]
35. Combination gemcitabine/cisplatin therapy and ERCC1 expression for resected pancreatic adenocarcinoma: Results of a Phase II prospective trial.
Postlewait LM; Ethun CG; Kooby DA; Sarmiento JM; Chen Z; Staley CA; Brutcher E; Adsay V; El-Rayes B; Maithel SK
J Surg Oncol; 2016 Sep; 114(3):336-41. PubMed ID: 27501338
[TBL] [Abstract][Full Text] [Related]
36. The role of ATM and 53BP1 as predictive markers in cervical cancer.
Roossink F; Wieringa HW; Noordhuis MG; ten Hoor KA; Kok M; Slagter-Menkema L; Hollema H; de Bock GH; Pras E; de Vries EG; de Jong S; van der Zee AG; Schuuring E; Wisman GB; van Vugt MA
Int J Cancer; 2012 Nov; 131(9):2056-66. PubMed ID: 22323184
[TBL] [Abstract][Full Text] [Related]
37. Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with non-squamous histology.
Jeong SH; Lee HW; Han JH; Kang SY; Choi JH; Jung YM; Choi H; Oh YT; Park KJ; Hwang SC; Sheen SS; Oh YJ; Kim JH; Lim HY
Jpn J Clin Oncol; 2008 Oct; 38(10):661-9. PubMed ID: 18772168
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of Ki-67 and p53 expression in curatively resected non-small cell lung cancer.
Ahn HK; Jung M; Ha SY; Lee JI; Park I; Kim YS; Hong J; Sym SJ; Park J; Shin DB; Lee JH; Cho EK
Tumour Biol; 2014 Jun; 35(6):5735-40. PubMed ID: 24737581
[TBL] [Abstract][Full Text] [Related]
39. Gemcitabine and Taxane Adjuvant Therapy with Chemoradiation in Resected Pancreatic Cancer: A Novel Strategy for Improved Survival?
Kanji ZS; Edwards AM; Mandelson MT; Sahar N; Lin BS; Badiozamani K; Song G; Alseidi A; Biehl TR; Kozarek RA; Helton WS; Picozzi VJ; Rocha FG
Ann Surg Oncol; 2018 Apr; 25(4):1052-1060. PubMed ID: 29344878
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab: A Post Hoc Analysis of the PETACC-8 Trial.
Taieb J; Zaanan A; Le Malicot K; Julié C; Blons H; Mineur L; Bennouna J; Tabernero J; Mini E; Folprecht G; Van Laethem JL; Lepage C; Emile JF; Laurent-Puig P
JAMA Oncol; 2016 May; 2(5):643-653. PubMed ID: 26768652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
